Corrigendum to "Bone marrow mesenchymal stem cells alleviate the daunorubicin-induced subacute myocardial injury in rats through inhibiting infiltration of T lymphocytes and antigen-presenting cells" [Biomed. Pharmacother. 121 (2020) 109157].

Qiuru Chen, Yuxin Zhang,Haojie Zhu,Xiaohong Yuan,Xiaofeng Luo,Xueqiong Wu,Shaozhen Chen,Yongquan Chen,Jingjing Xu,Hajji Ally Issa,Zhihong Zheng,Jianda Hu,Ting Yang

Biomedicine & Pharmacotherapy（2023）

引用 6|浏览18

暂无评分

摘要

•This study explores the effect of BMSCs on DNR-induced subacute myocardial injury.•Pre-perfusion of BMSCs for 3 days decreases DNR-induced subacute myocardial injury.•BMSCs combined with DZR further alleviate DNR-induced subacute myocardial injury.•BMSCs improve cardiac function by inhibiting infiltration of T lymphocytes and APCs.•This study provides novel theoretical basis for treating myocardial injury.

查看译文

关键词

Bone marrow mesenchymal stem cells,Subacute myocardial injury,Cardiac function,T lymphocytes,Antigen-presenting cells

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要